PMID: 9187954Jun 1, 1997Paper

Nosocomial Candida. Epidemiology, transmission, and prevention

Infectious Disease Clinics of North America
W L Wright, R Wenzel

Abstract

The NNIS and the newly established SCOPE data indicate that the relative proportion of organisms causing nosocomial bloodstream infections has changed over the last decade, with Candida species now being firmly established as one of the most frequent agents. The epidemiology of nosocomial candidemia is continually being refined, but established predisposing factors including immunosuppression and malignancies, use of broad spectrum antibiotics, and use of indwelling central catheters remain as significant risk factors. The high cost of health care and greater attention to continuous quality improvement will stimulate better and more effective ways of diagnosing and treating candida infections using combined clinical and microbiologic acumen. There is room for optimism as newer antifungal agents with reduced toxicities have impact on therapy of candidal infections. Aggressive development of still more agents and reformulations of older agents continue in earnest. Even greater consolation comes from the increased awareness of lay and medical personnel alike regarding the appropriate and judicious use of antimicrobial agents.

Citations

Sep 13, 2007·British Journal of Hospital Medicine·Badrul HussainSusan L Lightman
Jun 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·E CenciL Romani
Oct 6, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D G WolfM Shapiro
Dec 8, 2000·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·S P GoldbergW L Holman
Jul 14, 2001·Nature·M C Lorenz, G R Fink
Sep 11, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Laura PuzniakLouis Polish
Mar 10, 2006·The Journal of Antimicrobial Chemotherapy·Lori L BurrowsCharles M Deber
Jun 1, 2012·Journal of Clinical Microbiology·Andrew M BormanElizabeth M Johnson
Jan 19, 2016·Frontiers in Microbiology·Roberto Pérez-Torrado, Amparo Querol
Jul 26, 2018·Frontiers in Cellular and Infection Microbiology·Jesus A RomoJose L Lopez-Ribot
Oct 26, 2000·Hospital Medicine·M EllisB de Pauw
Aug 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN NIAID Mycoses Study Group
Nov 13, 2009·Indian Journal of Pediatrics·Sunit Singhi, Akash Deep
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·R SantangeloD S Perlin
Jun 16, 2001·Antimicrobial Agents and Chemotherapy·A SafdarD S Perlin
Mar 7, 2003·Journal of Medical Microbiology·P Lewis WhiteRosemary A Barnes
Apr 5, 2002·Microbiology·Tige R RustadTheodore C White
May 19, 2007·Medical Mycology·Joshua PerlrothBrad Spellberg
Jul 16, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lucia Garcia San MiguelSantiago Moreno
Jan 11, 2013·Journal of Clinical Microbiology·Andrew M BormanElizabeth M Johnson
Sep 5, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Mustafa BakirAysegul Yagci
Sep 3, 1999·Antimicrobial Agents and Chemotherapy·R PetraitieneT J Walsh
Aug 5, 2000·The Journal of Hospital Infection·S F CostaA S Levin
Oct 30, 2001·Journal of Clinical Microbiology·Y C ChenB T Cookson
Jan 18, 2008·Journal of Clinical Microbiology·Andrew M BormanElizabeth M Johnson
May 28, 2003·The Journal of Hospital Infection·C C KibblerJ A Wilson
Nov 1, 2003·The Lancet Infectious Diseases·Philippe EggimannDidier Pittet
Jul 13, 2021·Infectious Diseases·Fleischer Cn KoteyEric S Donkor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Matthew E FalagasKonstantinos Z Vardakas
Future Microbiology
Amy ChangDavid L Horn
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale
Ghada N Al-Rawahi, Diane L Roscoe
© 2021 Meta ULC. All rights reserved